Aspirin for CV Risk Reduction To Be or Not To Be? That is the Question
Not Available
Main Author: | Soneil Guptha |
---|---|
Format: | Article |
Language: | English |
Published: |
Sonali Sharma on behalf of Rajasthan University of Health Sciences
2023-07-01
|
Series: | RUHS Journal of Health Sciences |
Subjects: | |
Online Access: | https://ruhsjhs.in/articleDetails.php?artid=TXpRPQ== |
Similar Items
-
Heart Failure with Preserved Ejection Fraction (HFpEF): Part 1 Review of Experience and Evidence in PARAGON-HF with Commentary
by: Soneil Guptha; Eteri Tsetskhladze
Published: (2023-07-01) -
Heart Failure with Preserved Ejection Fraction (HFpEF): Part 2 Review of Experience and Evidence with SGLT-2 Inhibitors and Commentary
by: Soneil Guptha, Eteri Tsetskhladze
Published: (2023-06-01) -
Are Doctors Unhealthy? Managing Cardiovascular Risks in Physicians
by: Rajeev Gupta
Published: (2023-09-01) -
Hypertension Gene Risk Score in Diagnosis and Prediction of Complications
by: Sonali Sharma
Published: (2023-08-01) -
Reducing the Risks of Nuclear War – The Role of Health Professionals
by: Kamran Abbasi , Parveen Ali , Virginia Barbour , Kirsten Bibbins-Domingo , Marcel GM Olde Rikkert , Andy Haines , Ira Helfand , Richard Horton , Bob Mash , Arun Mitra , Carlos Monteiro , Elena N Naumova , Eric J Rubin , Tilman Ruff , Peush Sahni , James Tumwine , Paul Yonga , Chris Zielinski
Published: (2023-09-01)